Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Gynecol Obstet Fertil ; 38(3): 183-92, 2010 Mar.
Artículo en Francés | MEDLINE | ID: mdl-20153682

RESUMEN

High risk may be defined as either an absolute risk greater than 20 % or a relative risk greater than 4. Concerning breast and ovarian cancer, high risk patients include carriers of a constitutive deleterious mutation of BRCA1 or BRCA2 genes, patients with a significant family history of breast or ovarian cancer, and patients who have been diagnosed a benign breast lesion with a high risk of degeneration, i.e. atypical hyperplasia. Following up such patients relies on specific strategies. A center including a large panel of physicians involved in the various modalities for patients' management (geneticians, radiologists, gynecologists, plastic surgeons, pathologists, endocrinologists, psychologists, medical oncologists) has been created at Tenon Hospital with this purpose. The collaboration of these different specialists with the referent physician of the patient allows for the definition and the implementation of a patient-centered follow-up continuously updated to take into account the different periods of a woman's life, according to best practices recommendations and the evolving state-of-the art.


Asunto(s)
Neoplasias de la Mama/prevención & control , Unidades Hospitalarias/organización & administración , Neoplasias Ováricas/prevención & control , Especialización , Mama/patología , Enfermedades de la Mama/patología , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Femenino , Francia , Genes BRCA1 , Genes BRCA2 , Predisposición Genética a la Enfermedad , Humanos , Hiperplasia , Mutación , Neoplasias Ováricas/genética , Médicos , Derivación y Consulta , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA